![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LK Simmons, PC May, KJ Tomaselli, RE Rydel, KS Fuson, EF Brigham, S Wright, I Lieberburg, GW Becker and DN Brems
Lilly Research Laboratories, Division of Eli Lilly and Company, Indianapolis, Indiana 46285.
Amyloid beta peptide (A beta), the major protein constituent of senile plaques in patients with Alzheimer's disease, is believed to facilitate the progressive neurodegeneration that occurs in the latter stages of this disease. Early attempts to characterize the structure-activity relationship of A beta toxicity in vitro were compromised by the inability to reproducibly elicit A beta-dependent toxicity across different lots of chemically equivalent peptides. In this study we used CD spectroscopy to demonstrate that A beta secondary structure is an important determinant of A beta toxicity. Solubilized A beta was maximally toxic when the peptide adopted a beta-sheet conformation. Three of the four A beta lots tested had a random coil conformation and were weakly toxic or inactive, whereas the single A beta lot exhibiting toxic activity at low peptide concentrations had significant beta-sheet structure. Incubation of the weakly toxic A beta lots in aqueous stock solutions for several days before use induced a time-dependent conformational transition from random coil to beta-sheet and increased A beta toxicity in three different toxicity assays. Furthermore, the secondary structure of preincubated A beta was dependent upon peptide concentration and pH, so that beta-sheet structures were attenuated when peptide solutions were diluted or buffered at neutral and basic pH. Our data could explain some of the variable toxic activity that has been associated with A beta in the past and provide additional support for the hypothesis that A beta can have a causal role in the molecular neuropathology of Alzheimer's disease.
This article has been cited by other articles:
|
|
 |
|
  K. J. Barnham, V. B. Kenche, G. D. Ciccotosto, D. P. Smith, D. J. Tew, X. Liu, K. Perez, G. A. Cranston, T. J. Johanssen, I. Volitakis, et al. Platinum-based inhibitors of amyloid-{beta} as therapeutic agents for Alzheimer's disease PNAS, May 13, 2008; 105(19): 6813 - 6818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Origlia, M. Righi, S. Capsoni, A. Cattaneo, F. Fang, D. M. Stern, J. X. Chen, A. M. Schmidt, O. Arancio, S. D. Yan, et al. Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-{beta}-Mediated Cortical Synaptic Dysfunction J. Neurosci., March 26, 2008; 28(13): 3521 - 3530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Nguyen and C. K. Hall Kinetics of Fibril Formation by Polyalanine Peptides J. Biol. Chem., March 11, 2005; 280(10): 9074 - 9082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wogulis, S. Wright, D. Cunningham, T. Chilcote, K. Powell, and R. E. Rydel Nucleation-Dependent Polymerization Is an Essential Component of Amyloid-Mediated Neuronal Cell Death J. Neurosci., February 2, 2005; 25(5): 1071 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yao, T.-V. V. Nguyen, and C. J. Pike {beta}-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w J. Neurosci., February 2, 2005; 25(5): 1149 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Nguyen, A. J. Marchut, and C. K. Hall Solvent effects on the conformational transition of a model polyalanine peptide Protein Sci., November 1, 2004; 13(11): 2909 - 2924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Shanmugam and P. L. Polavarapu Structure of A{beta}(25-35) Peptide in Different Environments Biophys. J., July 1, 2004; 87(1): 622 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Kim and R. M. Murphy Mechanism of Accelerated Assembly of {beta}-Amyloid Filaments into Fibrils by KLVFFK6 Biophys. J., May 1, 2004; 86(5): 3194 - 3203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jang, C. K. Hall, and Y. Zhou Thermodynamics and stability of a {beta}-sheet complex: Molecular dynamics simulations on simplified off-lattice protein models Protein Sci., January 1, 2004; 13(1): 40 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jang, C. K. Hall, and Y. Zhou Assembly and Kinetic Folding Pathways of a Tetrameric {beta}-Sheet Complex: Molecular Dynamics Simulations on Simplified Off-Lattice Protein Models Biophys. J., January 1, 2004; 86(1): 31 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Kim, T. J. Gibson, and R. M. Murphy Targeted Control of Kinetics of {beta}-Amyloid Self-association by Surface Tension-modifying Peptides J. Biol. Chem., October 17, 2003; 278(42): 40730 - 40735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Cirrito, P. C. May, M. A. O'Dell, J. W. Taylor, M. Parsadanian, J. W. Cramer, J. E. Audia, J. S. Nissen, K. R. Bales, S. M. Paul, et al. In Vivo Assessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-{beta} Metabolism and Half-Life J. Neurosci., October 1, 2003; 23(26): 8844 - 8853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Prasad, W. C. Cole, and K. C. Prasad Risk Factors for Alzheimer's Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment J. Am. Coll. Nutr., December 1, 2002; 21(6): 506 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Lashuel, D. M. Hartley, D. Balakhaneh, A. Aggarwal, S. Teichberg, and D. J. E. Callaway New Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE J. Biol. Chem., November 1, 2002; 277(45): 42881 - 42890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jang, C. K. Hall, and Y. Zhou Protein Folding Pathways and Kinetics: Molecular Dynamics Simulations of beta -Strand Motifs Biophys. J., August 1, 2002; 83(2): 819 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Okazawa and S. Estus The JNK/c-Jun cascade and Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2002; 17(2): 79 - 88. [Abstract] [PDF]
|
|
|
|
|
|
S.-R. Ji, Y. Wu, and S.-f. Sui Cholesterol Is an Important Factor Affecting the Membrane Insertion of beta -Amyloid Peptide (Abeta 1-40), Which May Potentially Inhibit the Fibril Formation J. Biol. Chem., February 15, 2002; 277(8): 6273 - 6279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Tucker, M. Kihiko, J. N. Caldwell, S. Wright, T. Kawarabayashi, D. Price, D. Walker, S. Scheff, J. P. McGillis, R. E. Rydel, et al. The Plasmin System Is Induced by and Degrades Amyloid-beta Aggregates J. Neurosci., June 1, 2000; 20(11): 3937 - 3946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Grundman Vitamin E and Alzheimer disease: the basis for additional clinical trials1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 630s - 636s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. O. Tjernberg, D. J. E. Callaway, A. Tjernberg, S. Hahne, C. Lilliehook, L. Terenius, J. Thyberg, and C. Nordstedt A Molecular Model of Alzheimer Amyloid beta -Peptide Fibril Formation J. Biol. Chem., April 30, 1999; 274(18): 12619 - 12625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. S. Benzinger, D. M. Gregory, T. S. Burkoth, H. Miller-Auer, D. G. Lynn, R. E. Botto, and S. C. Meredith Propagating structure of Alzheimer's beta -amyloid(10-35) is parallel beta -sheet with residues in exact register PNAS, November 10, 1998; 95(23): 13407 - 13412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pappolla, P. Bozner, C. Soto, H. Shao, N. K. Robakis, M. Zagorski, B. Frangione, and J. Ghiso Inhibition of Alzheimer beta -Fibrillogenesis by Melatonin J. Biol. Chem., March 27, 1998; 273(13): 7185 - 7188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. McLaurin, T. Franklin, P. E. Fraser, and A. Chakrabartty Structural Transitions Associated with the Interaction of Alzheimer beta -Amyloid Peptides with Gangliosides J. Biol. Chem., February 20, 1998; 273(8): 4506 - 4515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jordan, M. F. Galindo, R. J. Miller, C. A. Reardon, G. S. Getz, and M. J. LaDu Isoform-Specific Effect of Apolipoprotein E on Cell Survival and beta -Amyloid-Induced Toxicity in Rat Hippocampal Pyramidal Neuronal Cultures J. Neurosci., January 1, 1998; 18(1): 195 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Estus, H. M. Tucker, C. van Rooyen, S. Wright, E. F. Brigham, M. Wogulis, and R. E. Rydel Aggregated Amyloid-beta Protein Induces Cortical Neuronal Apoptosis and Concomitant "Apoptotic" Pattern of Gene Induction J. Neurosci., October 15, 1997; 17(20): 7736 - 7745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lalowski, A. Golabek, C. A. Lemere, D. J. Selkoe, H. M. Wisniewski, R. C. Beavis, B. Frangione, and T. Wisniewski The "Nonamyloidogenic" p3 Fragment (Amyloid beta 17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid J. Biol. Chem., December 27, 1996; 271(52): 33623 - 33631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Good and R. M. Murphy Effect of beta -amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron PNAS, December 24, 1996; 93(26): 15130 - 15135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Biere, B. Ostaszewski, E. R. Stimson, B. T. Hyman, J. E. Maggio, and D. J. Selkoe Amyloid beta -Peptide Is Transported on Lipoproteins and Albumin in Human Plasma J. Biol. Chem., December 20, 1996; 271(51): 32916 - 32922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Backstrom, G. P. Lim, M. J. Cullen, and Z. A. Tokes Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-beta Peptide (1-40) J. Neurosci., December 15, 1996; 16(24): 7910 - 7919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ghanta, C.-L. Shen, L. L. Kiessling, and R. M. Murphy A Strategy for Designing Inhibitors of beta -Amyloid Toxicity J. Biol. Chem., November 22, 1996; 271(47): 29525 - 29528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. McLaurin and A. Chakrabartty Membrane Disruption by Alzheimer beta -Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides. IMPLICATIONS FOR NEUROTOXICITY J. Biol. Chem., October 25, 1996; 271(43): 26482 - 26489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Giulian, L. J. Haverkamp, J. H. Yu, W. Karshin, D. Tom, J. Li, J. Kirkpatrick, Y.-M. Kuo, and A. E. Roher Specific Domains of beta -Amyloid from Alzheimer Plaque Elicit Neuron Killing in Human Microglia J. Neurosci., October 1, 1996; 16(19): 6021 - 6037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tomiyama, A. Shoji, K.-i. Kataoka, Y. Suwa, S. Asano, H. Kaneko, and N. Endo Inhibition of Amyloid beta Protein Aggregation and Neurotoxicity by Rifampicin J. Biol. Chem., March 22, 1996; 271(12): 6839 - 6844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Pike, M. J. Overman, and C. W. Cotman Amino-terminal Deletions Enhance Aggregation of beta-Amyloid Peptides in Vitro J. Biol. Chem., October 13, 1995; 270(41): 23895 - 23898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. J. Huang, D.-S. Yang, P. E. Fraser, and A. Chakrabartty Alternate Aggregation Pathways of the Alzheimer beta -Amyloid Peptide. AN IN VITRO MODEL OF PREAMYLOID J. Biol. Chem., November 10, 2000; 275(46): 36436 - 36440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yoshiike, K. Tanemura, O. Murayama, T. Akagi, M. Murayama, S. Sato, X. Sun, N. Tanaka, and A. Takashima New Insights on How Metals Disrupt Amyloid beta -Aggregation and Their Effects on Amyloid-beta Cytotoxicity J. Biol. Chem., August 17, 2001; 276(34): 32293 - 32299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. McLaurin, R. Golomb, A. Jurewicz, J. P. Antel, and P. E. Fraser Inositol Stereoisomers Stabilize an Oligomeric Aggregate of Alzheimer Amyloid beta Peptide and Inhibit Abeta -induced Toxicity J. Biol. Chem., June 9, 2000; 275(24): 18495 - 18502. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
